Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Net Asset Value(s)

3 Aug 2021 13:18

RNS Number : 4445H
Athelney Trust PLC
03 August 2021
Β 

Athelney Trust PLC

Β 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 292.8p at 31 July 2021.

Fund Manager's comment for July 2021

Financial markets have for the most part been positive as a result of better public health outcomes following large scale vaccinations of the population in developed economies. Despite some economies not performing as expected, global economic data during the month highlighted a theme of global demand continuing to outstrip supply. In an interesting twist, Chinese technology stocks declined sharply as Beijing launched a regulatory assault on education businesses and companies that handle large amounts of data, as well as an overhaul of how Chinese groups list on stock markets outside their country.

In the United Kingdom, officials pressed ahead with fully unwinding restrictions in spite of an increase in case counts and scrapped quarantine for fully vaccinated EU and US visitors. The latest Red Flag Alert research for Q2 2021 recorded 650,000 businesses in 'significant financial distress1' which represents a decline of 10% from the highest recorded number of significantly distressed businesses in Q1 2021 (723,000).

Dividend income from our investments continues to improve and YTD is well ahead of last year's receipts, contributing to the 5.81% increase in the total value of our portfolio over the month. Costs were well contained which culminated in a 5.39% increase in the NAV for the month. By comparison, the FTSE 100 was down by 0.07%, the FTSE 250 Index was up by 2.56% and the AIM All Share Index was up by 0.22%. The small caps were mixed, with the Fledging Index down by 0.35% while the Small Cap Index was up by 0.24%. Elsewhere, Global markets ended the month in positive territory, with the MSCI increasing by 1.72% and the S&P 500 up by 2.27%.

There were minor changes to the portfolio holdings during the month as we top sliced our exposure to AEW and added to our holding in Fevertree Drinks. Cash received by way of dividends resulted in a slight increase in the overall cash position which currently represents 2.6% of the portfolio value as at the end of July.

Β 

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "Portfolio Details".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (licence no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has over AU$1500m under its management including four listed investment companies, three listed in Australia and one in the UK:

Β· Flagship Investments (ASX code:FSI)

AUD50m https://flagshipinvestments.com.au

Β· Barrack St Investments (ASX code: BST)

AUD25m www.barrackst.com

Β· Global Masters Fund Limited (ASX code: GFL)

AUD25m www.globalmastersfund.com.au

Β· Athelney Trust plc (LSE code: ATY)

GBP5m www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

Β The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is one of only "22 investment companies that have increased their dividend every year between 10 and 20 years - the next generation of dividend heroes" (as at 20/03/2018). See link

www.theaic.co.uk/aic/news/press-releases/next-generation-of-dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVBDGDIIBGDGBX
Date   Source Headline
25th Jan 201910:08 amRNSDirectorate Change
22nd Jan 20192:52 pmRNSResult of EGM
11th Jan 20193:00 pmRNSEGM Shareholder Statement
4th Jan 201910:26 amRNSNet Asset Value(s)
28th Dec 20184:00 pmRNSNotice of Extraordinary General Meeting
19th Dec 20181:43 pmRNSDirector/PDMR Shareholding
19th Dec 20189:09 amRNSDirector/PDMR Shareholding
17th Dec 201811:28 amRNSStatement re Corporate Action
5th Dec 201810:43 amRNSNet Asset Value(s)
3rd Dec 20189:38 amRNSDirectorate Change
5th Nov 20189:39 amRNSNet Asset Value(s)
3rd Oct 20183:20 pmRNSNet Asset Value(s)
1st Oct 201811:43 amRNSDirectorate Change
5th Sep 201810:54 amRNSNet Asset Value(s)
3rd Aug 20188:30 amRNSNet Asset Value(s)
20th Jul 20187:00 amRNSHalf-year Report
4th Jul 20189:48 amRNSNet Asset Value(s)
25th Jun 20189:15 amRNSChange of Adviser
4th Jun 201812:52 pmRNSNet Asset Value(s)
2nd May 20182:12 pmRNSNet Asset Value(s)
30th Apr 20182:03 pmRNSDirectorate Change
16th Apr 20188:54 amRNSDirector/PDMR Shareholding
9th Apr 201811:35 amRNSNet Asset Value(s)
22nd Mar 201810:14 amRNSAGM Statement
6th Mar 201812:50 pmRNSNet Asset Value(s)
16th Feb 20187:00 amRNSAnnual Financial Report
6th Feb 20189:05 amRNSNet Asset Value(s)
3rd Jan 201810:51 amRNSNet Asset Value(s)
5th Dec 201710:15 amRNSNet Asset Value(s)
2nd Nov 201712:52 pmRNSNet Asset Value(s)
3rd Oct 201711:24 amRNSNet Asset Value(s)
4th Sep 201712:00 pmRNSNet Asset Value(s)
3rd Aug 20178:34 amRNSNet Asset Value(s)
25th Jul 20177:00 amRNSHalf-year Report
5th Jul 201710:59 amRNSNet Asset Value(s)
5th Jul 20179:53 amRNSHolding(s) in Company
5th Jun 20179:51 amRNSNet Asset Value(s)
8th May 20179:20 amRNSNet Asset Value(s)
5th Apr 20179:16 amRNSNet Asset Value(s)
31st Mar 201711:52 amRNSAGM Statement
6th Mar 20179:53 amRNSNet Asset Value(s)
24th Feb 20177:00 amRNSAnnual Financial Report
3rd Feb 201712:17 pmRNSNet Asset Value(s)
6th Jan 20178:54 amRNSNet Asset Value(s)
5th Dec 20169:13 amRNSNet Asset Value(s)
3rd Nov 20168:45 amRNSNet Asset Value(s)
4th Oct 20169:34 amRNSNet Asset Value(s)
21st Sep 20169:44 amRNSDirector/PDMR Shareholding
2nd Sep 201612:35 pmRNSNet Asset Value(s)
2nd Aug 20168:52 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.